153 related articles for article (PubMed ID: 10593015)
21. Testosterone deficiency: which patients should you screen and treat?
Sadovsky R; Dhindsa S; Margo K
J Fam Pract; 2007 May; 56(5 Suppl Testosterone):S1-20; quiz S21-3. PubMed ID: 17475159
[No Abstract] [Full Text] [Related]
22. Testosterone replacement therapy for the primary care physician.
Casey RW; Barkin J
Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068
[TBL] [Abstract][Full Text] [Related]
23. Case report: treatment of androgen deficiency in the aging male.
Hernandez A; Baum N
Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
[TBL] [Abstract][Full Text] [Related]
24. Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46.
Ponholzer A; Rauchenwald M; Madersbacher S
Eur Urol; 2005 Jul; 48(1):170-1; author reply 171. PubMed ID: 15967269
[No Abstract] [Full Text] [Related]
25. [Comparative characteristics of testosterone preparations for androgen-replacing therapy in male hypogonadism].
Iudovskiĭ SO; Segal AS; Pushkar' DIu
Urologiia; 2006; (3):83-4, 86-8. PubMed ID: 16889100
[No Abstract] [Full Text] [Related]
26. Androgens and cognitive function.
Cherrier MM
J Endocrinol Invest; 2005; 28(3 Suppl):65-75. PubMed ID: 16044582
[TBL] [Abstract][Full Text] [Related]
27. Effect of aromatizable and unaromatizable androgen replacement in hypogonadal men on GH responsiveness.
Gleeson HK; Shalet SM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):109-15. PubMed ID: 18549466
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
29. [Hormone replacement Up-to-date. Clinical practice of androgen replacement therapy].
Kawa G; Matsuda T
Clin Calcium; 2007 Sep; 17(9):1414-8. PubMed ID: 17767032
[TBL] [Abstract][Full Text] [Related]
30. Testosterone replacement therapy for late-onset hypogonadism.
Cunningham GR
Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
[TBL] [Abstract][Full Text] [Related]
31. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
32. Testosterone replacement therapy for older men.
Wald M; Meacham RB; Ross LS; Niederberger CS
J Androl; 2006; 27(2):126-32. PubMed ID: 16474018
[No Abstract] [Full Text] [Related]
33. [Analysis of the statues of patients visiting our specialized clinic for hypogonadal men: 5-year experience].
Kawa G; Taniguchi H; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2009 Feb; 55(2):87-92. PubMed ID: 19301613
[TBL] [Abstract][Full Text] [Related]
34. Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121-30.
Ponholzer A; Madersbacher S
Eur Urol; 2009 May; 55(5):e92; author reply e93-4. PubMed ID: 19081175
[No Abstract] [Full Text] [Related]
35. [Hormone replacement therapy in men: practical aspects].
Gamidov SI; Shcherbakov DV; Tazhetdinov OKh; Pavlovichev AA; Iremashvili VV
Urologiia; 2011; (4):68, 70-3. PubMed ID: 22066247
[No Abstract] [Full Text] [Related]
36. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
37. Advances in male hormone substitution therapy.
Qoubaitary A; Swerdloff RS; Wang C
Expert Opin Pharmacother; 2005 Aug; 6(9):1493-506. PubMed ID: 16086637
[TBL] [Abstract][Full Text] [Related]
38. Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.
Doğan BA; Karakılıç E; Tuna MM; Arduç A; Berker D; Güler S
Clin Endocrinol (Oxf); 2015 Mar; 82(3):422-8. PubMed ID: 25280063
[TBL] [Abstract][Full Text] [Related]
39. Testosterone supplementation: why and for whom?
Gooren L
Aging Male; 2003 Sep; 6(3):184-99. PubMed ID: 14628499
[TBL] [Abstract][Full Text] [Related]
40. Voice changes after androgen therapy for hypogonadotrophic hypogonadism.
Akcam T; Bolu E; Merati AL; Durmus C; Gerek M; Ozkaptan Y
Laryngoscope; 2004 Sep; 114(9):1587-91. PubMed ID: 15475787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
